INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

Información del proyecto

DE-ESCALATE

Identificador del acuerdo de subvención: 101104574

DOI

10.3030/101104574

Fecha de la firma de la CE 21 Abril 2023

Fecha de inicio 1 Junio 2023

Fecha de finalización 31 Mayo 2028

Financiado con arreglo a

• Health

Coste total

€ 7 185 663,75

Aportación de la UE

€ 7 185 663,00

Coordinado por

EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL
Belgium

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (5)

Plan for dissemination and exploitation

The plan that will describe project strategy for communication and dissemination

Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster 1

Conclusions of common annual meeting of the ‘Diagnosis and treatment’ cluster

Policy brief 1

Policy brief formulating recommendations based on the research and innovation strand of the ‘Diagnosis and treatment’ annual cluster meeting

Data Management Plan

The DMP will describe which data/variables are collected, the standards used, how they are processed and stored and how they could be accessed.The preparation of the Data Management Plan will include a common chapter on the ‘Diagnosis and treatment’ cluster. The aim is of the chapter is to address commonalities in data standards, data validation, data protection and foster data exchange.

Initial common work plan for scientific collaboration under the ‘Diagnosis and treatment’ cluster

Other (1)

Project website is online

launch of the project dedicated public website

Publicaciones

Peer reviewed articles (1)

"EORTC 2238 ""De-Escalate"": a pragmatic trial to revisit intermittent androgen deprivation therapy in the era of new androgen receptor pathway inhibitors."

Autores: Grisay G, Turco F, Litiere S, Fournier B, Patrikidou A, Gallardo E, McDermott R, Alanya A, Gillessen S, Tombal B
Publicado en: Frontiers in oncology, 2024, ISSN 1664-3224
Editor: Frontiers media
DOI: 10.3389/FONC.2024.1391825

Conference proceedings (1)

EORTC GUCG 2238 De-escalate: A pragmatic trial to revisit intermittent androgen-deprivation therapy in metastatic hormone-naïve prostate cancer in the era of new AR pathway inhibitors.

Autores: Guillaume Grisay, Fabio Turco, Anna Patrikidou, Enrique Gallardo Díaz, Raymond S. McDermott, Saskia Litiere, Beatrice Fournier, Silke Gillessen, and Bertrand F. Tombal
Publicado en: Journal of Clinical Oncology, 2024, ISSN 0732-183X
Editor: American Society of Clinical Oncology
DOI: 10.1200/JCO.2024.42.4_suppl.TPS2